StuetzABaumannKGrassbergerMWolffKMeingassnerJG. Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus. Int Arch Allergy Immunol. 2006;141(3):199-212. doi:10.1159/000095289
2.
SiegfriedECJaworskiJCHebertAA. Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice. Am J Clin Dermatol. 2013;14(3):163-178. doi:10.1007/s40257-013-0020-1
3.
CeilleyREisenthalA. The unintended effects of a boxed warning. J Clin Aesthet Dermatol. 2009;2(9):33-39.